Wire Stories

Category Added in a WPeMatico Campaign

news_6

Daiichi Sankyo Announces Clinical Research Collaboration to Evaluate DS-1062 in Combination with KEYTRUDA® (pembrolizumab) in Metastatic Non-Small Cell Lung Cancer

TOKYO & MUNICH & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that it has entered into...

news_6

Indian OTT and Pay TV Market Analysis and Trajectory 2018-2025 – Netflix, Amazon Prime Video, Disney+, Apple TV+, Zee5 and More – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "India OTT and Pay TV Forecasts" report has been added to ResearchAndMarkets.com's offering. This 36-page PDF report covers...

news_6

New data show first-line triplet regimen of pembrolizumab, Herzuma® (biosimilar trastuzumab) and chemotherapy are effective in treatment of HER2-positive advanced gastric cancer

Data from a phase Ib/II trial show a first-line triple combination therapy of pembrolizumab, Herzuma®(biosimilar trastuzumab) and chemotherapy was effective...

news_6

Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn® Disinfectant & Sanitizer Has Received Approval to Be Entered Into the Australian Register of Therapeutic Goods (ARTG) for use against COVID-19

PETALUMA, Calif.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for...

news_6

Harro Höfliger and Vaxxas Announce Alliance to Develop Industrial-scale Aseptic Processing Line for Vaccine Products Based on Vaxxas’ High Density Microarray Patch (HD-MAP)

Needle-free Vaxxas HD-MAP can enhance routine vaccination with potential to revolutionize vaccination in pandemic response; produce more patient-doses from limited...